2019 annual financial data

TScan Therapeutics 2019 Net margin

Direct answer

Net margin was Not calculable.

Operating income was -14.21M USD and net income was -13.66M USD.
Operating cash flow was -12.52M USD.

Get free TScan Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-14.21M USD
Net income
-13.66M USD
Operating cash flow
-12.52M USD